Kenji Tai

E6201 [(3S,4R,5Z,8S,9S,11E)-14-(Ethylamino)-8, 9,16-trihydroxy-3,4-dimethyl-3,4,9,19-tetrahydro-1H-2-benzoxacyclotetradecine-1,7(8H)-dione], a Novel Kinase Inhibitor of Mitogen-Activated Protein Kinase/Extracellular Signal-Regulated Kinase Kinase (MEK)-1 and MEK Kinase-1: In Vitro Characterization of Its Anti-Inflammatory and Antihyperproliferative Activities

Masaki Goto, Jesse C. Chow, Kenzo Muramoto et al. · Journal of Pharmacology and Experimental Therapeutics · 2009 · 52 citations

Syntheses and Structure−Activity Relationships of 5,6,7,8-Tetrahydro-5,5,8,8-tetramethyl-2-quinoxaline Derivatives with Retinoic Acid Receptor α Agonistic Activity

K. Kikuchi, Shigeki Hibi, Hiroyuki Yoshimura et al. · Journal of Medicinal Chemistry · 2000 · 42 citations · Full text

Medicinal Chemistry, Pharmaceutical Chemistry, Derivative (Chemistry) +14

Discovery of Novel and Potent Retinoic Acid Receptor α Agonists:  Syntheses and Evaluation of Benzofuranyl-pyrrole and Benzothiophenyl-pyrrole Derivatives

Hiroyuki Yoshimura, K. Kikuchi, Shigeki Hibi et al. · Journal of Medicinal Chemistry · 2000 · 30 citations

Molecular Pharmacology, Medicinal Chemistry, Pharmaceutical Science +15

Syntheses and Structure−Activity Relationships of Novel Retinoid X Receptor Agonists

Shigeki Hibi, K. Kikuchi, Hiroyuki Yoshimura et al. · Journal of Medicinal Chemistry · 1998 · 27 citations

Combinatorial Chemistry, Medicinal Chemistry, Pharmaceutical Science +14

Mutagenesis of the fourth calcium-binding domain of yeast calmodulin

Isao Matsuura, Eiichiro Kimura, Kenji Tai et al. · Journal of Biological Chemistry · 1993 · 23 citations · Full text